Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet
The cholesterol gallstones diseases (CGD) is highly correlated with metabolic syndrome and type 2 diabetes. The present study aimed to investigate preventive effects of pioglitazone (PIO), an antidiabetic drug...
Source: Lipids in Health and Disease - Category: Lipidology Authors: Tao Han, Yangge Lv, Shijia Wang, Tao Hu, Hao Hong and Zan Fu Tags: Research Source Type: research
More News: Actos | Cholesterol | Diabetes | Diabetes Type 2 | Diets | Endocrinology | Gallstones | Guinea Health | Lipidology | Metabolic Syndrome | Nutrition | Study